Eastgate Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	2008 - 2012
Period Ending	Aug '25 Aug 6, 2025	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012	2008 - 2012
Market Capitalization	3	10	6	3	-	-	Upgrade
Market Cap Growth	-89.36%	77.66%	58.66%	-	-	-	Upgrade
Enterprise Value	-	11	7	4	-	-	Upgrade
Last Close Price	0.00	0.03	0.02	0.04	-	-	Upgrade
PS Ratio	23.06	-	41.86	-	-	-	Upgrade
PB Ratio	-0.60	-2.13	-2.23	-2.49	-	-	Upgrade
EV/Sales Ratio	-	-	52.04	-	-	-	Upgrade
Debt / Equity Ratio	-0.58	-0.37	-0.55	-0.72	-0.40	-0.74	Upgrade
Asset Turnover	-	-	0.34	-	-	-	Upgrade
Quick Ratio	0.01	-	0.04	0.18	0	0.14	Upgrade
Current Ratio	0.02	-	0.04	0.18	0	0.15	Upgrade
Return on Assets (ROA)	-	-	-667.76%	-1085.92%	-1174.50%	-	Upgrade
Earnings Yield	-120.32%	-30.33%	-77.47%	-140.89%	-	-	Upgrade
FCF Yield	-56.99%	-3.97%	-10.29%	-38.56%	-	-	Upgrade
Buyback Yield / Dilution	-87.04%	-59.16%	-286.67%	-56.60%	-32.51%	-105.29%	Upgrade

Updated Mar 4, 2019. Source: S&P Global Market Intelligence. Standard template. Financial Sources.